Aromaxyl 25 mg

KALPA PHARMACEUTICALS AROMAXYL

Aromaxyl is an oral medication containing exemestane as its active substance, with each tablet providing 25 mg of this aromatase inhibitor.

DRUG COMPOSITION

Each Aromaxyl tablet comprises 25 mg of exemestane, a potent aromatase inhibitor used to regulate estrogen levels.

PHARMACEUTICAL FORM

Aromaxyl is formulated as an oral tablet, ensuring convenient and precise dosing.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical group: Antineoplastic and immunomodulating agents; ATC code: L02BG06.

PHARMACOLOGICAL PROPERTIES

Exemestane irreversibly inhibits aromatase, the enzyme responsible for converting androgens into estrogens. By reducing estrogen levels, Aromaxyl is effective in treating estrogen-dependent conditions.

PROFILE

• Chemical name: (8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione
• Chemical formula: C20H24O2
• Percentage of anabolic activity: Not a steroid
• Percentage of androgenic activity: Not a steroid
• Active half life: Approximately 24 hours
• Recommended dosage: 25 mg per day for breast cancer; may vary in other applications
• Acne: Not reported
• Bloating (water retention): Not reported
• HBR: Low
• Hepatic toxicity: Rare
• Aromatization: Inhibits aromatase, reducing estrogen conversion

THERAPEUTICAL INDICATIONS

Aromaxyl is indicated for the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is also employed off-label in hormone replacement therapy (HRT) for transgender individuals.

DOSES AND METHOD OF ADMINISTRATION

The typical dose of Aromaxyl for breast cancer is 25 mg once daily after a meal. Dosage adjustments may be made based on individual patient response.

CYCLE/STACKING

Solo cycle:

• Aromaxyl is primarily used as a supportive therapy and is not typically administered in solo cycles.

Cutting cycle:

• Incorporated into cutting cycles to manage estrogen-related side effects of aromatizable steroids.

Bulking cycle:

• Used in bulking cycles to control estrogen levels when aromatizable compounds are part of the stack.

POST CYCLE THERAPY

PCT may include Aromaxyl to prevent estrogen-related side effects. For example:

• Aromaxyl: 25 mg every other day for 4 weeks

SIDE EFFECTS

Potential side effects include hot flashes, fatigue, and joint pain. Regular medical monitoring is advised.

CONTRAINDICATIONS

Contraindications include hypersensitivity to exemestane, premenopausal women, and individuals with a history of estrogen-sensitive cancers.

OVERDOSE

No specific overdose symptoms are reported. In case of overdose, supportive measures should be taken, and medical attention sought.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Aromaxyl may affect bone health; therefore, monitoring bone mineral density is recommended. Caution is advised in patients with cardiovascular risk factors.

INTERACTIONS WITH OTHER DRUGS

Aromaxyl may interact with medications affecting liver enzymes. Consultation with a healthcare professional is essential.

PRESENTATION, PACKAGING

30 tablets.

STORAGE

Aromaxyl should be stored according to the manufacturer's instructions, typically in a cool, dry place, and kept out of the reach of children.

LEGAL STATUS

The legal status of Aromaxyl may vary by jurisdiction. It is typically available only with a prescription.

LAB TEST RESULTS

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Kalpa Pharmaceuticals
India

EXTERNAL LINKS

• Exemestane Wiki, wikipedia.org
• Exemestane: Uses, Dosage, Side Effects, Warnings, drugs.com
• Exemestane Oral: Uses, Side Effects, Interactions, Pictures, webmd.com.